 HOUSTON, Feb. 22, 2021 GLOBE NEWSWIRE -- Salarius Pharmaceuticals, Inc. Nasdaq: SLRX, a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that Salarius CEO David Arthur will present during the virtual Diamond Equity Research Emerging Growth Invitational Conference taking place Wednesday, February 24, 2021. All registered conference attendees will be able to view the live virtual presentation. 